51

KRO

Kronos Worldwide ($KRO): Executives' $150K 'Bottom Buying' vs 64% Stock Crash Reality

08/12/2025 20:33

Sentiment

Cluster Buy

C-Level

Summary

  • Kronos Worldwide insiders collectively purchased $150,000 worth of shares on August 11 amid a 64% stock decline
  • Q2 2025 loss of 8 cents per share significantly missed analyst expectations of 14 cents profit, continuing weak performance
  • EU anti-dumping duties on Chinese titanium dioxide imports provide potential pricing power improvement

POSITIVE

  • Persistent and substantial insider buying by CEO and senior executives demonstrates strong management confidence
  • EU anti-dumping duties of 0.25-0.74 euros per kilogram on Chinese titanium dioxide provide 5-year pricing protection
  • Extreme valuation discount with P/E 9.39x, P/S 0.31x, P/B 0.69x all significantly below industry peers
  • Analyst projections of 8.4% average annual revenue growth over three years, substantially outpacing 4.5% industry average
  • TiO2 pigments serve essential consumer products providing defensive characteristics and lower economic sensitivity

NEGATIVE

  • Q2 2025 loss of 8 cents per share significantly missed analyst expectations, showing continued earnings deterioration
  • Levered free cash flow of negative $130.76 million over trailing twelve months indicates serious cash outflow issues
  • Cash holdings of only $18.9 million combined with 72.11% debt-to-equity ratio raises liquidity concerns
  • Broader chemical sector demand weakness and tariff uncertainties create persistent industry headwinds
  • 3.96% dividend yield questionable for sustainability given ongoing cash flow pressures

Expert

From a specialty chemicals industry perspective, Kronos presents a complex mix of typical 'bottom' signals alongside structural concerns. While concentrated insider buying and EU anti-dumping tariffs are positive, persistent cash flow deterioration poses serious near-term risks. The structural improvement of the TiO2 market will be critical to future investment thesis.

Previous Closing Price

$5.54

+0.49(9.70%)

Average Insider Trading Data Over the Past Year

$5.88

Purchase Average Price

$0

Sale Average Price

$273.47K

Purchase Amount

$0

Sale Amount

Transaction related to News

Trading Date

Filing Date

Insider

Title

Type

Avg Price

Trans Value

08/13/2025

08/13/2025

Sale

$

Kronos Worldwide ($KRO) insiders have been aggressively purchasing shares amid a steep stock decline, drawing market attention to this specialty chemicals company. Based in Texas, Kronos is a global leader in titanium dioxide (TiO2) pigment production, serving essential industries including paints, coatings, plastics, and paper manufacturing since its founding in 1916. The most striking development occurred on August 11, 2025, when insiders collectively purchased over $150,000 worth of shares in a single day. EVP Amy Samford bought 3,000 shares ($14,475), Officer Michael Simmons acquired 5,000 shares ($24,350), Officer Bart Reichert purchased a substantial 20,000 shares ($99,200), and Treasurer Bryan Hanley bought 2,500 shares ($12,250). Reichert's 20,000-share purchase stands out as particularly significant in scale. This represents the third wave of concentrated insider buying, following CEO Andrew Nace's consecutive purchases in August 2024 and Director Kevin Kramer's 14,000-share acquisition ($104,424) in March 2025. Such persistent buying by senior executives strongly suggests management views the current stock price as significantly undervalued. However, the stock's performance tells a dramatically different story. $KRO has plummeted 64% from $13.43 in June 2024 to around $5 in August 2025. The decline accelerated particularly in late July through early August, dropping from $6.02 to $4.86 as broader market volatility intensified. Poor financial performance has been the primary driver of the stock's decline. In Q2 2025, $KRO reported a loss of 8 cents per share, missing analyst expectations of a 14-cent profit by a wide margin. Revenue also declined 1.2% year-over-year to $494.4 million, falling short of the $504.7 million estimate. More concerning is the company's levered free cash flow of negative $130.76 million over the trailing twelve months, indicating persistent cash outflows. Despite these challenges, structural changes may work in $KRO's favor. In November 2024, the EU approved anti-dumping duties on Chinese titanium dioxide imports. Duties of 0.25 euros per kilogram for Anhui Gold Star Group products and 0.74 euros for LB Group products will be effective for five years starting January 2025. This provides significant pricing protection against Chinese competition. Analysts forecast average annual revenue growth of 8.4% over the next three years, substantially outpacing the 4.5% projected for the broader U.S. chemicals industry. Current valuation metrics show extreme discounts: P/E ratio of 9.39x, price-to-sales of 0.31x, and price-to-book of 0.69x - all significantly below industry peers. The critical variable investors must monitor is cash flow improvement. With only $18.9 million in cash and a debt-to-equity ratio of 72.11%, liquidity constraints pose genuine concerns. While the 3.96% dividend yield exceeds industry averages, sustainability remains questionable given cash flow pressures. Broader chemical sector headwinds add another layer of complexity. August 2025's disappointing U.S. manufacturing and services data, combined with tariff uncertainties, pressured chemical stocks across the board. However, TiO2 pigments serve essential consumer products like paints, cosmetics, and food items, providing some defensive characteristics. The next critical inflection point will be Q3 earnings results. Whether the concentrated insider buying in August translates into actual business improvements remains to be seen. Additionally, the EU anti-dumping tariff effects should become more apparent in H2 2025 results, potentially showing improved pricing power. Current analyst price targets of $8.00 suggest 32% upside potential from current levels. However, without fundamental earnings recovery, insider buying alone may not sustain a meaningful stock rebound. A long-term perspective focusing on undervaluation and potential structural improvements appears warranted for patient value-oriented investors.

Sign up and access more data free.

With account, you can enjoy the following benefits:

  • Access advanced features of insider transaction screener.

  • Read insider transaction news without any limits.